Breakthrough SARS-CoV-2 Infections in Patients With MS on Disease-Modifying Therapies
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Multiple Sclerosis (Houndmills, Basingstoke, England)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies
Mult. Scler. 2022 Jun 23;[EPub Ahead of Print], I Schiavetti, C Cordioli, ML Stromillo, M Teresa Ferrò, A Laroni, E Cocco, G Cola, L Pasquali, MT Rilla, E Signoriello, R Iodice, A Di Sapio, R Lanzillo, F Caleri, P Annovazzi, A Conte, G Liberatore, F Ruscica, R Docimo, S Bonavita, M Ulivelli, P Cavalla, F Patti, D Ferraro, M Clerico, P Immovilli, M Di Filippo, M Salvetti, MP SormaniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.